|
|
News Breaks | | | | September 20, 2012 | | 06:04 EDT |  | TROV | Trovagene, Strand Life Sciences to commercialize urine-based HPV test
Trovagene and Strand Life Sciences Pvt Ltd., of Bangalore, India, completed their agreement to validate and commercialize Trovagene's proprietary urine-based Human Papillomavirus, or HPV, test for clinical diagnostic and carrier screening use. Trovagene's urine-based HPV test is designed to allow for completely non-invasive HPV carrier screening. Strand's initial target market is an estimated population of over 450M women between the ages 18 and 65 in India and South Asia. | |
|
News For TROV From The Last 14 Days Check below for free stories on TROV the last two weeks. |
|
|
| There are no results for TROV |
|
|
|
|
|
|
